Impact of COVID-19 vaccination coverage on global disability burden of Guillain-Barré syndrome
Abstract The global burden of Guillain-Barré syndrome (GBS), an immune-mediated neuropathy, remains poorly characterized during the COVID-19 pandemic. We analyzed age-standardized years lived with disability (YLD) for GBS from 1990 to 2021 using GBD 2021 data and COVID-19 vaccination coverage from O...
| Published in: | npj Vaccines |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-08-01
|
| Online Access: | https://doi.org/10.1038/s41541-025-01239-1 |
